Tesamorelin

COA by Freedom Diagnostics
Lot PH-te20-0714
COA 2512050194
Reported 12/8/2025
Verified

Average Purity

99.298%

Test Method

HPLC-MS

Identity

Pass

Endotoxin

Pass (<0.01 EU/mg)

Tesamorelin

Product

Tesamorelin

View full product details and compound information.

01

Sample Identification

LabFreedom Diagnostics
Document TypeCertificate of Analysis
COA Number2512050194
Accession NumberNumber
Search CodeProt2512050194
ClientProtide Health
ProductTesamorelin
LotPH-te20-0714
Received Date09/08/2026
Reported Date12/8/2025

02

Purity & Quality Analysis

Purity (HPLC)

  • Average Purity 99.298%
  • Purity Vial 1 99.51%
  • Purity Vial 2 99.53%

Net Peptide Content

  • Net Peptide Average 20.44 mg
  • Net Peptide Vial 1 12.79 mg
  • Net Peptide Vial 2 12.61 mg

Identity & Appearance

  • Identity Pass
  • Appearance White Lyophilized Powder

Endotoxin (LAL)

  • Replicate 1 Pass (<0.01 EU/mg)
  • Replicate 2 Pass (<0.01 EU/mg)

03

Testing Methods & COA

Certificate of Analysis

Source COA scan, Tesamorelin lot PH-te20-0714

Mass Identification

TESAMORELIN

Analysis Method

HPLC with UV Detection Coupled with Mass Spectrometry.

Average Purity Result

99.298%

Third-Party Verification

Third-party testing completed at Freedom Diagnostics, on 12/8/2025.

  • COA Number2512050194
  • Reported12/8/2025
  • LabFreedom Diagnostics

04

Test History for Tesamorelin

8 independent lab tests on file for this product.